The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Sensus Healthcare, Inc. (SRTS) . Sensus Healthcare currently has ...

Slavica/E+ via Getty Images Investment Thesis Sensus Healthcare (NASDAQ:NASDAQ:SRTS) is a company that offers equipment to treat skin problems, including non-melanoma cancer. These products have shown strong demand, but are usually affected during economically unstable periods such as 2020 and 2023, causing years as bad as the previous one. During 2024 the company has been recovering and management has begun exciting initiatives to create recurring revenue streams to provide more stability and also recently ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Sensus Healthcare, Inc. (SRTS) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Sensus Healthcare, Inc. is one of 1019 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank conside ...

From a technical perspective, Sensus Healtheare, Inc. (SRTS) is looking like an interesting pick, as it just reached a key level of support. SRTS recently overtook the 20-day moving average, and this suggests a short-term bullish trend. The 20-day simple moving average is a well-liked trading tool because it provides a look back at a stock's price over a 20-day period. Additionally, short- term traders find this SMA very beneficial, as it smooths out short-term price trends and shows more trend reversal sig ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done. The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the s ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share SRTS The NASDAQ Stock Market, LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ...

Sensus Healthcare, Inc. (SRTS) closed the last trading session at $6.07, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10 indicates a 64.7% upside potential. The mean estimate comprises three short-term price targets with a standard deviation of $0. While the lowest estimate of $10 indicates a 64.7% increase from the current price level, the most optimistic analyst ...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA, IR Joseph Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO Conference Call Participants Jason Wittes - ROTH Anthony Vendetti - Maxim Group Eduardo Martinez-Montes - H.C. Wainwright & Co. Operator Good day and welcome to the Sensus Healthcare Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Pleas ...

Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 233.33%. A quarter ago, it was expected that this company would post a loss of $0.04 per share when it actually produced earnings of $0.14, delivering a surprise of 450%. Over the last four quarters, the compa ...

Exhibit 99.1 TECHNOLOGY THAT CAP Sensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second Quarter ● Revenues of $9.2 million compare with $4.5 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $2.1 million compares with negative $1.0 million a year ago ● "Fair Deal Agreement" recurring revenue program gaining momentum with 15 agreements signed to date Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (A ...